Synthesis 2025; 57(05): 973-977
DOI: 10.1055/s-0043-1775433
psp

A Scalable, Chromatography-Free Synthesis of the Potent and Highly Selective ERβ Agonist EGX358

a   Department of Chemistry, Marquette University, P.O. Box 1881, Milwaukee, WI 53201-1881, USA
,
Dulanjali Thennakoon
b   Estrigenix Therapeutics, Inc., 1225 Discovery Parkway, Suite 255C, Wauwatosa, WI 53226, USA
,
Edward A. Wetzel
a   Department of Chemistry, Marquette University, P.O. Box 1881, Milwaukee, WI 53201-1881, USA
,
a   Department of Chemistry, Marquette University, P.O. Box 1881, Milwaukee, WI 53201-1881, USA
b   Estrigenix Therapeutics, Inc., 1225 Discovery Parkway, Suite 255C, Wauwatosa, WI 53226, USA
› Author Affiliations
This work was supported by grant R15GM118304 from the National Institute of General Medical Sciences and grant R43AG079715 from the National Institute on Aging.


Abstract

4-[trans-4-(Hydroxymethyl)cyclohexyl]phenol (EGX358) is a potent and highly selective estrogen receptor beta (ERβ) agonist which has demonstrated efficacy for moderation of a chemically induced hot flash and for memory consolidation in an ovariectomized mouse model for menopause. An improved synthetic route to EGX358 is reported which proceeds in four steps and which is chromatography-free.

Supporting Information



Publication History

Received: 11 November 2024

Accepted after revision: 11 December 2024

Article published online:
22 January 2025

© 2025. Thieme. All rights reserved

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany